+766.2%
MRNA vs ACGL
+20.5%
+745.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ACGL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.0% | +0.1% | -7.0% | -6.9% |
| 7D | -4.2% | -1.2% | -3.0% | -4.7% |
| 30D | +7.0% | +12.8% | -5.8% | +15.4% |
| 3M | +263.4% | +12.3% | +251.1% | +291.5% |
| 6M | +334.3% | +15.8% | +318.5% | +375.9% |
| YTD | +684.5% | +13.9% | +670.6% | +772.8% |
| 1Y | +766.2% | +19.0% | +747.1% | +871.0% |
| All | +766.2% | +20.5% | +745.7% | +871.0% |
Cumulative growth
Daily Returns
Daily percentage return beside ACGL.
Daily Out/Under-Performance
Portfolio return minus ACGL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ACGL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ACGL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling